Contents
Academy · Research Data, Analytics & AI · Observational Clinical Study Designs: Design Families, STROBE Reporting and Confounding
Observational Clinical Study Designs: Design Families, STROBE Reporting and Confounding
An observational study does not lack a design just because no one assigned the exposure. It has a design -- cohort, case-control, or cross-sectional -- and that design, not the absence of randomisation, is what determines what the study can and cannot conclude.
An observational clinical study design is one in which the investigator records, rather than assigns, participants’ exposures. The three main families (cohort, case-control and cross-sectional) differ in how they sample participants and in the type of effect estimate and causal inference they can support.
Learning objectives
- The three main observational design families and the sampling logic that distinguishes them.
- What STROBE requires of observational study reporting, and why it covers all three families under one guideline.
- Why the absence of randomisation specifically creates a confounding problem that design and analysis both have to address.
- Criteria for selecting among the three families for a given research question.
Common misconceptions
- “Observational studies are a single, interchangeable design type.” Cohort, case-control and cross-sectional designs differ fundamentally in sampling logic and in the effect measures and temporal inferences they support; selection among them is a design decision rather than a formality.
- “Only randomised trials need a reporting guideline.” STROBE exists specifically because observational studies require the same explicit reporting discipline regarding design, population, definition of exposure and outcome, and control of confounding that CONSORT provides for randomised trials.
The three principal observational design families
A cohort study defines a population by exposure status and follows it forward to observe outcomes, as discussed in the article on cohort studies. A case-control study, by contrast, samples by outcome status, identifying people who have the outcome and a comparison group who do not, and examines exposure history retrospectively, as discussed in the article on case-control studies. A cross-sectional study measures exposure and outcome at a single point in time in a defined population; it can describe association but, because exposure and outcome are measured simultaneously, generally cannot establish which preceded the other. The STROBE statement by von Elm and colleagues treats these three as the core observational designs addressed by its reporting guidance.
STROBE requirements and their application across all three design families
The STROBE statement (Strengthening the Reporting of Observational Studies in Epidemiology) provides a single, 22-item checklist covering cohort, case-control and cross-sectional studies, with items that specify design-appropriate wording for each family; for example, it provides distinct guidance on how each design should describe participant selection, since the definition of the sampled population differs by design1. The use of one guideline for all three designs reflects a deliberate choice: the designs share the central reporting challenge of observational research (transparent description of exposure, outcome and confounder measurement), even though their sampling logic differs.
Confounding as a persistent problem in observational design
Because exposure is observed rather than assigned in every observational design, the groups compared may differ systematically in ways related to the outcome, independently of the exposure itself; this is confounding. The STROBE reporting items on confounder measurement and statistical adjustment exist because, unlike a randomised trial, in which randomisation is expected to balance confounders on average, an observational study must identify, measure and statistically address confounding explicitly and report transparently how this was done1.
Key points
Key points
Cohort, case-control and cross-sectional designs differ in sampling logic and in what effect measure and temporal inference they support, which is why choosing among them is a design decision tied to the research question -- and because none of the three randomises exposure, confounding has to be addressed explicitly in design and analysis, which is exactly what the STROBE reporting guideline's confounder-related items require being disclosed.
Practical application
Practical application
- The design should be matched to the sampling logic of the research question. A cohort design is suited to a forward-looking question with a defined exposure, a case-control design to a question concerning a rare outcome that requires efficient sampling, and a cross-sectional design only to a question that a single time-point snapshot genuinely answers.
- Reporting should follow the correct STROBE design-specific items. The cohort, case-control or cross-sectional wording that STROBE provides for the relevant checklist items should be used, rather than a generic version that obscures the design.
- Confounders should be identified and addressed explicitly. The confounders considered, the methods by which they were measured and the statistical method used to adjust for them should be listed, rather than reliance being placed on the design alone to address the problem.
Frequently asked questions
Generally not directly, because exposure and outcome are measured at the same time point, which makes temporal order difficult to establish; the design is primarily suited to describing prevalence and association.
Yes. The STROBE guidance covers nested case-control and case-cohort designs as variants within its case-control reporting items.
No. Observational studies use statistical methods (such as multivariable adjustment, propensity scores or restriction) to address measured confounding, although these methods cannot account for confounders that were not measured.
References
- von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative. Strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007;335(7624):806-808. read 10 October 2026. View on The BMJ
Every source above is a peer-reviewed article, a publisher’s record of one, or a standard issued by the body that owns it. Each carries the date it was last read. Where a standard moves, this article is revised rather than left up with a note.
How to cite this article
Pick your referencing style and copy it. Your university or target journal may vary the punctuation — check its guide if it has one.
Pubrica Academy. (2026, October 10). Observational Clinical Study Designs: Design Families, STROBE Reporting and Confounding. Pubrica. https://pubrica.com/academy/concepts-definitions/observational-clinical-study-designs/
Pubrica Academy. “Observational Clinical Study Designs: Design Families, STROBE Reporting and Confounding.” Pubrica, 10 Oct. 2026, pubrica.com/academy/concepts-definitions/observational-clinical-study-designs/.
Pubrica Academy (2026) Observational Clinical Study Designs: Design Families, STROBE Reporting and Confounding. Pubrica. Available at: https://pubrica.com/academy/concepts-definitions/observational-clinical-study-designs/ (Accessed: 15 October 2026).
Pubrica Academy. “Observational Clinical Study Designs: Design Families, STROBE Reporting and Confounding.” Pubrica. October 10, 2026. https://pubrica.com/academy/concepts-definitions/observational-clinical-study-designs/
Pubrica Academy, ‘Observational Clinical Study Designs: Design Families, STROBE Reporting and Confounding’ (Pubrica, 10 October 2026) <https://pubrica.com/academy/concepts-definitions/observational-clinical-study-designs/> accessed 15 October 2026.
Pubrica Academy. Observational Clinical Study Designs: Design Families, STROBE Reporting and Confounding. [Internet]. Pubrica; 2026 Oct 10 [cited 2026 Oct 15]. Available from: https://pubrica.com/academy/concepts-definitions/observational-clinical-study-designs/
Pubrica Academy, “Observational Clinical Study Designs: Design Families, STROBE Reporting and Confounding,” Pubrica, Oct. 10, 2026. [Online]. Available: https://pubrica.com/academy/concepts-definitions/observational-clinical-study-designs/
@misc{observational_clinical_study_designs_2026,
author = {{Pubrica Academy}},
title = {Observational Clinical Study Designs: Design Families, STROBE Reporting and Confounding},
howpublished = {Pubrica},
year = {2026},
month = {oct},
url = {https://pubrica.com/academy/concepts-definitions/observational-clinical-study-designs/},
note = {Accessed: <span data-cite-acc="iso">2026-10-15</span>}
}This article is written to be learned from. Cite it if you are referring to what it says; if you are using the evidence behind it, cite the sources listed above instead.
Observational design selection stub
For use when selecting among cohort, case-control and cross-sectional designs.
Research question: ____ Is outcome rare? (favours case-control): Y/N Is exposure well-defined and measurable at baseline? (favours cohort): Y/N Is only a single time-point snapshot needed? (favours cross-sectional): Y/N Selected design: ____ Key confounders identified: ____ Planned adjustment method: ____
Pubrica AcademyWritten and maintained by Pubrica’s subject matter experts. Articles are revised when the underlying standards change, and each article states the date on which it was last reviewed.
How Pubrica can help
Pubrica’s research-writing team assists in selecting an appropriate observational design for the research question and prepares the manuscript against the correct STROBE design-specific checklist items, with the handling of confounders made explicit.